Vitamin D plays a crucial role in conjunction with calcium to promote strong bone health. It is found in foods such as fatty fish, eggs, and fortified milk. Pregnant women require more vitamin D than what is typically provided in standard prenatal vitamins. Numerous intervention studies highlight the positive effects of sufficient vitamin D levels during pregnancy on both maternal and fetal health. Cochrane researchers have examined this evidence extensively.
Vitamin D metabolites are transferred across the placenta in significant amounts and are converted to active 1,25(OH)2D by fetal kidneys. However, the exact molecular mechanisms and limiting factors for vitamin D uptake by the placenta remain unclear, as do the pathways regulating metabolite levels within the placenta. Observational studies have linked maternal 25(OH)D concentrations to cognitive performance in offspring, yet randomized clinical trials exploring these associations have yielded inconclusive results. The Institute of Medicine recommends a minimum of 400 IU per day of vitamin D for pregnant women, while Cochrane’s current guidelines state that there are no specific requirements for vitamin D during pregnancy, which contradicts the growing body of research. It is essential to stay updated on the latest findings in this field. This blog aims to provide an overview of the most recent evidence. The author, Emily Carter, is a Cochrane UK Fellow and an Obstetrics and Gynaecology Registrar, and she serves as the editor for the Cochrane Library systematic review on antenatal vitamin D supplementation.
The impact of vitamin D on brain development and function has been the focus of extensive research. Beyond its role in neuronal differentiation and axonal connectivity, vitamin D regulates calcium/calmodulin-dependent protein kinase II (CAM kinase II) activity, which is linked to long-term synaptic memory. Furthermore, vitamin D deficiency during pregnancy has been associated with a higher risk of adverse birth outcomes, including preeclampsia, premature rupture of membranes, and low birth weight. A recent randomized controlled trial found that midgestational vitamin D supplementation reduced the risk of preeclampsia by 60%. Women at high risk during pregnancy are encouraged to consider vitamin D supplementation, and their obstetricians should monitor serum 25(OH)D levels throughout pregnancy to ensure optimal vitamin D status. Additional trials are planned to further investigate the benefits of antenatal vitamin D on maternal and infant health. Until then, a daily intake of 400 IU is recommended.
Vitamin D significantly influences the immune system. Research indicates that vitamin D deficiency is linked to an increased risk of infections and autoimmune conditions. In the fetus, the kidneys can activate 25(OH)D into 1,25(OH)2D, maintaining adequate levels of active vitamin D. This is crucial, as insufficient vitamin D can adversely affect immune function, leading to impaired defenses and a higher susceptibility to infections. Studies show that vitamin D supplementation during pregnancy can notably reduce the risk of certain complications. For instance, in women with high-risk pregnancies, those with 25(OH)D levels above 40 ng/mL experienced a 60% lower incidence of preterm birth compared to those with lower levels. Additionally, a post-hoc analysis of two vitamin D supplementation trials indicated that the occurrence of asthma and recurrent wheezing in offspring was halved for mothers with 25(OH)D levels above 30 ng/mL at the time of randomization.